Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-084934
Filing Date
2025-08-28
Accepted
2025-08-28 19:00:11
Documents
2
Period of Report
2025-08-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2524504-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2524504-1_3seq1.xml 3 1670
2 EXHIBIT 24 tm2524504d1_ex24.htm EX-24 12375
  Complete submission text file 0001104659-25-084934.txt   15677
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15 353 1 6960000
Mallinckrodt plc (Issuer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | State of Incorp.: L2 | Fiscal Year End: 1226
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ENDO HEALTH SOLUTIONS INC. 1400 ATWATER DRIVE MALVERN PA 19355
Business Address
Raciti Frank B. (Reporting) CIK: 0001877137 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35803 | Film No.: 251275235